Infliximab for Injection
Efficacy and safety are equivalent to the original drug (Johnson & Johnson/Merck & Co.
The first infliximab biosimilar marketed in China
Infliximab for Injection (Reminton), a recombinant anti-TNF-alpha chimeric monoclonal antibody, was approved for marketing by the National Medical Products Administration (NMPA) on July 14, 2021. It is the first infliximab biosimilar marketed in China. Taking advantage of CHO cell expression system, Remin_x005f ton has been proved with good efficacy, better safety, and lower immunogenicity in clinical studies.
Indications:
Crohn's disease in adults and children over 6 years of age, stulizing Crohn's disease,
ulcerative colitis in adults, ankylosing spondylitis, rheumatoid arthritis, and psoriasis.
Recommended reading
Related products
-
Quick View
Vestibulum ante ipsum primis
$56.00Add to cartCras mollis dolor sed tempor iaculis. Duis ac ante quam. Donec nec justo erat. Nam a augue vel ex venenatis interdum sit amet ac quam. Interdum et malesuada fames ac ante ipsum primis in faucibus. Vestibulum erat lectus, cursus at dui in, fringilla commodo lectus. Quisque eu bibendum quam, eget euismod sem
-
Quick View
Morbi pulvinar augue lorem
Original price was: $78.00.$49.00Current price is: $49.00.Add to cartPhasellus massa felis, condimentum quis tortor mattis, condimentum varius eros. Vestibulum quis augue sem. Curabitur non vehicula elit, et cursus tortor. Quisque placerat velit nec nulla sodales, porttitor mattis tortor porta. Praesent gravida leo nibh, vel semper nulla lobortis vel. Donec nisl velit, iaculis ac dolor eget, blandit elementum urna.
-
Quick View
Pellentesque dignissim sapien semper
$78.00Add to cartCras luctus ultricies ex luctus malesuada. Fusce imperdiet interdum consectetur. Pellentesque dignissim sapien semper consequat sollicitudin. Phasellus iaculis libero ac placerat aliquam. Etiam a velit eu diam consequat vestibulum. Ut a malesuada nulla. Vivamus quis maximus nisi, vel molestie sapien. Nunc pharetra finibus elit sed consectetur.
-
Quick View
Sed pretium quam lacinia placerat
Original price was: $88.00.$74.00Current price is: $74.00.Add to cartSed et posuere lacus. Etiam convallis dui lorem, ut accumsan metus consectetur vitae. Curabitur ultricies ante ultricies blandit placerat. Phasellus fermentum, ligula sed vestibulum blandit, mi odio laoreet sem, a venenatis tellus felis eu justo. Nullam ut felis et mauris iaculis malesuada. Donec non turpis vel lectus accumsan rutrum. Vestibulum finibus nunc libero, vel dapibus mauris porta vitae.
Reviews
There are no reviews yet.